A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Aims To determine the efficacy and safety of nicotine transdermal therapy co‐administered with the nicotine antagonist, mecamylamine, compared to a nicotine transdermal patch alone (21 mg nicotine + 6 mg mecamylamine, 21 mg nicotine + 3 mg mecamylamine, and 21 mg nicotine + 0 mg mecamylamine). Design Multi‐center (n = 4), double‐blind, randomized, parallel group, repeat‐dose study. Setting Clinical laboratory. Participants A total of 540 subjects were enrolled into the study—135 from each of four sites; 180 patients in each of three treatment arms. Intervention Treatment was administered for the first 6 weeks of the 8‐week study. Patients were instructed to continue smoking for the first 2 weeks of treatment. Measurements The primary efficacy parameter was 4‐week continuous abstinence after the quit date, confirmed with an expired carbon monoxide of < 10 parts per million. Findings Analysis of the 4‐week continuous abstinence for the intent‐to‐treat population showed overall rates of 29% (nicotine + 6 mg mecamylamine), 29% (nicotine + 3 mg mecamylamine) and 23% (nicotine only) using the slip definition which allows smoking in the first 2 weeks after the quit date. Statistical analyses revealed no significant treatment differences. Analyses using the strict definition (no smoking after the quit date) yielded similar non‐significant group differences (29%, 27%, 26%). Conclusion If adding mecamylamine to nicotine replacement therapy (NRT) improves the chances of success at stopping smoking, the results of this study suggest that the effect is very small.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cox, L. S., Tiffany, S. T., & Christen, A. G. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200020032051 · Cited by 1,188
Self-citationNicotine replacement therapy for smoking cessation
Silagy, C., Lancaster, T., Stead, L., Mant, D., & Fowler, G. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub2 · Cited by 972
Cited by
Motives for smoking and their correlates in clients attending Stop Smoking treatment services
McEwen, A., West, R., & McRobbie, H. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802027248 · Cited by 120
Bacher, I., Wu, B., Shytle, D. R., & George, T. P. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903329102 · Cited by 96
Nicotine patch therapy prior to quitting smoking: a meta‐analysis
Shiffman, S., & Ferguson, S. G. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02138.x · Cited by 94
Metadata
- Authors
- Glover, E. D., Laflin, M. T., Schuh, K. J., Schuh, L. M., Nides, M., Christen, A. G., Glover, P. N., & Strnad, J. V.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2007-03-02
- Volume
- 102
- Issue
- 5
- Pages
- 795-802
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2001605886
- Cited by
- 38
- References
- 4
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers. https://app.cochat.ai/papers/10.1111/j.1360-0443.2007.01763.x
- The paper
- Glover, E. D., Laflin, M. T., Schuh, K. J., Schuh, L. M., Nides, M., Christen, A. G., Glover, P. N., & Strnad, J. V. (2007). A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers. Addiction. https://doi.org/10.1111/j.1360-0443.2007.01763.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.